Wilson Sonsini Goodrich & Rosati advised Tempus on the deal. Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
